Maggie Wong > Goodwin > San Francisco, United States > Lawyer Profile
Goodwin Offices

THREE EMBARCADERO CENTER
SAN FRANCISCO, CA 94111
CALIFORNIA
United States
- Firm Profile
- Go to...
Maggie Wong

Position
Partner
Career
Maggie Wong is a partner in Goodwin’s nationally recognized Life Sciences group. She represents private and public companies in the biotechnology, medical device and digital health industries, serving as a legal and business adviser across their entire corporate lifecycle. Ms. Wong provides strategic advice and corporate counseling to clients as they develop, in-license and acquire intellectual property and other assets, raise capital to fund their operations and seek to partner their technology or engage in exit transactions. Ms. Wong regularly counsels clients on pre-incorporation planning, seed and venture financings, initial public offerings and capital markets transactions, SEC compliance, and mergers and acquisitions. She also has substantial experience advising on licensing, collaboration, partnering, distribution, and other commercial agreements.
Ms. Wong is a member of Goodwin’s Partnership Committee. Ms. Wong is also a member of Goodwin’s PropSci practice which is focused on supporting the intersection of real estate and life sciences through thoughtful collaboration across the two practice areas. As a key contributor to the group and Steering Committee, Ms. Wong stays up to date on relevant market trends impacting the PropSci sector to effectively support clients involved in this space.
Education
JD, 2002, University of California, Berkeley School of Law (Order of the Coif) / BA, 1999, Yale University (cum laude)
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism